Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

ECG

Everus Construction to Acquire Epsilon Industries for $295M

Everus Construction Group said it will buy Epsilon Industries for $295 million in cash, a deal that expands its modular construction business and adds a company that expects about $250 million of revenue in 2026.

Epsilon’s 2026 revenue forecast of roughly $250 million implies the purchase price is about 1.2 times expected sales. The company said EBITDA margin will be in the low double digits, pointing to EBITDA of roughly $25 million to $30 million on that revenue base.

Epsilon brings more than 25 years of off-site construction experience and a workforce that includes more than 50 engineers and 120 skilled trade employees. It also operates across multiple facilities in the U.S. and Canada, giving Everus a broader modular footprint and access to markets including Florida, Texas, the mid-Atlantic and the Northeast.

Everus said the acquisition will be funded with cash on hand and borrowings under its credit facilities. The transaction is expected to close in the third quarter of 2026.

The deal gives Everus exposure to end markets including data centers, advanced manufacturing and healthcare. Epsilon’s services include design-assist, custom fabrication and turnkey field installation. Following these announcements, the company's shares moved 2.35%, and are now trading at a price of $125.8325. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS